The role of natural killer cells in curbing neuroinflammation
- 1 October 2007
- journal article
- review article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 191 (1-2) , 2-7
- https://doi.org/10.1016/j.jneuroim.2007.09.006
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-betaNeurological Sciences, 2007
- Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory PathwayImmunity, 2007
- Natural regulatory T cells: mechanisms of suppressionTrends in Molecular Medicine, 2007
- Regulation of natural killer cell activityCurrent Opinion in Immunology, 2006
- Regulatory CD56brightnatural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosisProceedings of the National Academy of Sciences, 2006
- Interferon γ Is Required for Activation-induced Death of T LymphocytesThe Journal of Experimental Medicine, 2002
- Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in VivoThe Journal of Experimental Medicine, 2001
- NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate CytokinesAnnual Review of Immunology, 1999
- One of the retinoic acid‐inducible cDNA clones in mouse embryonal carcinoma F9 cells encodes a novel isoenzyme of fructose 1,6‐bisphosphataseFEBS Letters, 1994
- Natural killer cell activity in multiple sclerosis patients treated with recombinant interferon-α2Clinical Immunology and Immunopathology, 1985